Browsing Tag
Gordon Naylor
2 posts
CSL (ASX: CSL) names new CEO. Can 5% profit growth sustain its rally?
CSL shares have recovered sharply from their June lows as investors anticipate an earnings turnaround. The appointment of Deborah Waterhouse brings fresh leadership, but flat revenue guidance and persistent weakness at CSL Vifor leave an important question about how much recovery is already reflected in the share price.
CSL (ASX: CSL) crashes 17.7% to A$98.59 after FY26 guidance cut and $5bn impairments
CSL cut FY26 NPATA to US$3.1 billion and flagged US$5 billion in impairments. The third downgrade in ten months is repricing the entire ASX healthcare sector.